Stock Price Quote

JENBURKT PHARMACEUTICALS LTD.

NSE : NABSE : 524731ISIN CODE : INE354A01013Industry : Pharmaceuticals & DrugsHouse : Private
BSE1226.15-5.15 (-0.42 %)
PREV CLOSE ( ) 1231.30
OPEN PRICE ( ) 1231.30
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5084
TODAY'S LOW / HIGH ( )1160.00 1251.30
52 WK LOW / HIGH ( ) 643.21375
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1985
Management Info
Ashish U Bhuta - Chairman Ashish U Bhuta - Managing Director
Registered Office

Address Nirmala Apartments,93 Jayprakash Road,Andheri (West),
Mumbai,
Maharashtra-400058

Phone 022-67603603

Email investor@jenburkt.com / info@jenburkt.com

Website www.jenburkt.com

Registrars Details
Bigshare Services Pvt Ltd
Office No S6-2, 6th Floor, Pinnacle Business Park,Next to Ahura Centre, Mahakali Caves Road,Andheri (E),Mumbai
Listing : BSE

NEWS

06Nov Jenburkt Pharmaceuticals informs about
With reference to letter No. JPL/CS/2140/2024 dated 5th November, 2024,..
28Oct Jenburkt Pharmaceuticals informs about
In continuation to letter No. JPL/CS/2126/2024 dated 23rd September, 202..
30Jul Jenburkt Pharmaceuticals informs about
Pursuant to Regulation 39(3) of the Securities and Exchange Board of Ind..
27Jul Jenburkt Pharmaceuticals informs about
With reference to letter No. JPL/CS/2110/2024 dated 26th July, 2024, Jen..
02Mar Jenburkt Pharmaceuticals informs about
In terms of Regulation 39(3) of the Securities and Exchange Board of Ind..

Financials

in Millions
QTR Sep 24 ANNUAL 24
Net Profit96.02259.76
Gross Profit 125.24 351.74
Operating Profit 132.79377.85
Net Sales 412.161419.66

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  27744.05 (1.36%)
M.Cap ( in Cr)58954.17
Divi's Lab (BSE)
peergroup  6171.05 (3.65%)
M.Cap ( in Cr)163821.99
Sanofi India (BSE)
peergroup  6396.80 (3.27%)
M.Cap ( in Cr)14732.23
Alkem Laboratories (BSE)
peergroup  5641.30 (3.36%)
M.Cap ( in Cr)67450.20
Torrent Pharma (BSE)
peergroup  3326.90 (3.84%)
M.Cap ( in Cr)112597.41

Shareholding Pattern

NON-INSTITUTION 53.29%
PROMOTERS 46.71%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Jenburkt Pharmaceuticals Ltd.

Jenburkt Pharmaceuticals Ltd. was incorporated in the year 1985. Its today's share price is 1226.15. Its current market capitalisation stands at Rs 541.14 Cr. In the latest quarter, company has reported Gross Sales of Rs. 1419.67 Cr and Total Income of Rs.1466.33 Cr. The company's management includes Pankaj A Dantwala, Krishnan Subharaman, Sumit A Thakkar, Hina R Mehta, Dilip H Bhuta, Ashish U Bhuta, Ashish U Bhuta, Ashish R Shah.

It is listed on the BSE with a BSE Code of 524731 , NSE with an NSE Symbol of and ISIN of INE354A01013. It's Registered office is at Nirmala Apartments,93 Jayprakash Road,Andheri (West)Mumbai-400058, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are DL Arora & Co, DR Mehta & Associates

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.